Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro

  • Conor G. Mc Donnell
  • , G. Shorten
  • , F. N.A.M. Van Pelt

Research output: Contribution to journalArticlepeer-review

Abstract

We have investigated the effects of the statins atorvastatin and fluvastatin on the cytochrome P450 3A4 enzyme (CYP 3A4)-mediated metabolism of midazolam in vitro, using pooled human liver microsomes. Midazolam was metabolised by human hepatic microsomes with a Michaelis-Menten constant (Km) of 5.25 (SD 1.2) μmol.1-1. Atorvastatin was a moderate competitive inhibitor of CYP 3A4 with an inhibitory constant (Ki) of 12.4 (95% CI 4.65-20.06) μmol.1-1. Fluvastatin was a weak non-competitive inhibitor of CYP 3A4 with a Ki of 94.3 (95% CI 55.01-133.5) μmol.1-1. Both atorvastatin and fluvastatin inhibit the CYP 3A4-mediated metabolism of midazolam in vitro. © 2005 Blackwell Publishing Ltd.
Original languageEnglish (Ireland)
Pages (from-to)747-753
Number of pages7
JournalAnaesthesia
Volume60
Issue number8
DOIs
Publication statusPublished - Aug 2005

Fingerprint

Dive into the research topics of 'Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro'. Together they form a unique fingerprint.

Cite this